Mumbai, Maharashtra, India Joined 14 May 2016
Darunavir 300 Tablet
Darunavir 300 Tablet

Darunavir 300 Tablet

Buyer Feedback
Posted by : Mr. Chetan Shivajirao Jadhav
Offered by : SAISMITA HEALTHCARE
Last updated on : Apr 11,2018
Product added on : Apr 10,2018
Send Inquiry Have a question?   Ask Supplier
Trade Information
Main Domestic MarketAll India
Certificationswe are Wide range of Trader or Supplier of All type of Anti HIV Drugs in India.
Product Description

We are an appreciated Exporter, Distributor, Trader and Supplier of Darunavir Tablets including Darunavir 300 Tablets in Mumbai, Maharashtra, India. Darunavir is a protease (PRO-tee-ayz) inhibitor. Darunavir is an antiviral medication that prevents human immunodeficiency virus (HIV) cells from multiplying in your body. Darunavir is utilized to treat HIV, which causes acquired immunodeficiency syndrome (AIDS). Apart from this, can be availed from us at market nominal price.

More
About the Supplier

Established in 2015, SAISMITA HEALTHCARE has been a leading name in offering top notch Anti Infective Drugs & Medicines. Located in Mumbai, Maharashtra, we offer the best quality Darunavir 300 Tablet to our customers at best prices in the industry.

  • Nature of Business
    Exporter / Wholesaler/Distributor / Supplier / Trading Company
  • Number of Employees
    7
  • Year of Establishment
    2015
  • Annual Turnover
    Rs 6 Crores
  • Working Days
    Monday - Sunday
Send your inquiry directly to this supplierReceiver's Company Name: SAISMITA HEALTHCARE

* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.

Send this inquiry to other Suppliers of similar products (?)
I agree to abide by all the Terms and Conditions of tradeindia.com
Contact Details
SAISMITA HEALTHCARE
Shop No. 5, Samta Co. Ho. Society, G.D. Ambekar Parel Village, Parel,
Mumbai, Maharashtra, 400012, India
Contact Supplier
Mr. Chetan Shivajirao Jadhav
Mr. Chetan Shivajirao JadhavProprietor
Last updated on : 23 July 2018 Report Incorrect Contact